ALKEM - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 4.2
Show all parameters (20 more)
🧾 Trade Setup
Entry Price: 5,470 ₹ – leveraging the current momentum and confirming a breakout above recent resistance at 5,440. Exit Guidance: Initial target price is 5,750 ₹, utilizing a 10% profit margin based on anticipated short-term movement. A trailing stop loss should be set around 5,200 ₹ to manage risk in case of negative news or significant market corrections. Verdict: This stock presents a compelling swing trading opportunity given the combination of strong earnings growth and an attractive entry price alongside clear potential for profit capture within a multi-day holding.
✅ Positive
The stock demonstrates strong recent earnings growth with PAT increasing from 294 Cr to 570 Cr in the last two quarters, supported by a healthy ROCE of 19.9%. Momentum is building as indicated by the rising DII holding and positive price movement triggered by recent news coverage, confirming analyst views on Alkem’s potential.
⚠️ Limitation
[Corrected] Stock P/E (29.4) is actually LOWER than Industry PE (34.8), a discount to industry peers rather than a premium - treat the valuation framing below with that in mind. Despite robust earnings, the high P/E ratio of 29.4 relative to an industry average of 34.8 indicates a premium valuation, potentially susceptible to profit-taking if growth expectations aren't met. The MACD signal (-74.2) suggests a short-term bearish trend that needs confirmation before committing significantly to a trade.
📈 Company Positive News
Recent news from Business Standard and Univest highlights positive price action driven by analyst ratings, suggesting increasing investor confidence in Alkem’s performance.
🏭 Industry
The pharmaceutical sector is currently experiencing moderate growth fueled by rising healthcare expenditure globally, with established players commanding premium valuations as evidenced by the industry's PE ratio of 34.8.